Медицинский совет, 2021 The evolution of polypharmacy, which for many years consisted of quantifying concurrently prescribed drugs, has led to an qualitative description: “appropriate polypharmacy”, which may be beneficial for some patients, and “problematic polypharmacy ...
M. V. Leonova
doaj +1 more source
Polypharmacy and potentially inappropriate medication use in geriatric oncology. [PDF]
, 2016 Polypharmacy is a highly prevalent problem in older persons, and is challenging to assess and improve due to variations in definitions of the problem and the heterogeneous methods of medication review and reduction.
Aparicio +65 more
core +2 more sources
El reto del envejecimiento y la complejidad farmacoterapéutica en el paciente VIH+ [PDF]
, 2018 Objective: To describe the current knowledge and management of aging and pharmacotherapeutic complexity in HIV + patients. Method: A review of literature was carried out, including articles, originals or reviews, published in English or Spanish, from ...
Abdel Kader Martín, Laila +3 more
core +3 more sources
Polypharmacy in elderly cancer patients : challenges and the way clinical pharmacists can contribute in resource-limited settings [PDF]
, 2019 The aim of this study was to address the problems associated with polypharmacy in elderly cancer patients and to highlight the role of pharmacists in such cases in resource‐limited settings.
Khanal, Saval +2 more
core +2 more sources
Clinical and Translational Science, 2023 Polypharmacy may cause adverse health outcomes in the elderly. This study examined the prevalence of continuous polypharmacy and hyper‐polypharmacy, factors associated with polypharmacy, and the most frequently prescribed medications among older adults ...
Ho Jin Cho +3 more
doaj +1 more source
Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial [PDF]
, 2016 In 2010 the 'Polymedication Check' (PMC), a pharmacist-led medication review, was newly introduced to be delivered independently from the prescriber and reimbursed by the Swiss health insurances.
Blozik, Eva +3 more
core +3 more sources
Coping with complexity: working beyond the guidelines for patients with multimorbidities [PDF]
, 2015 Primary care physicians believe they are delivering evidence-based care, understanding that adherence to evidence-based clinical guidelines results in tangible benefits in the populations for which they were developed.
Treadwell, Julian
core +6 more sources
Challenges of managing people with multimorbidity in today’s healthcare systems [PDF]
, 2015 Multimorbidity is a growing issue and poses a major challenge to health care systems around the world. Multimorbidity is related to ageing but many studies have now shown that it is also socially patterned, being more common and occurring at an earlier ...
Mercer, Stewart, Moffat, Keith
core +3 more sources
An overview of prevalence, determinants and health outcomes of polypharmacy
Therapeutic Advances in Drug Safety, 2020 A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are
Mina Khezrian +3 more
doaj +1 more source
Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study [PDF]
Intestinal Research, 2019 Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated with adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics associated with polypharmacy in
Jingzhou Wang +3 more
doaj +1 more source